G01N 2333/922
Ribonucleases
Official title: Ribonucleases (RNAses); Deoxyribonucleases (DNAses)
G01N2333/922 (Ribonucleases) appears on 187 US grants and 293 published applications in this corpus.
Search patents in G01N- Granted patents
- 187
- Published applications
- 293
- Assignees
- 200
- Inventors
- 760
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 11 | 0 |
| 1993 | 11 | 0 |
| 1994 | 8 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 1 | 0 |
| 1998 | 8 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 5 |
| 2003 | 3 | 8 |
| 2004 | 3 | 7 |
| 2005 | 2 | 8 |
| 2006 | 3 | 7 |
| 2007 | 5 | 6 |
| 2008 | 5 | 3 |
| 2009 | 1 | 3 |
| 2010 | 1 | 5 |
| 2011 | 1 | 5 |
| 2012 | 3 | 11 |
| 2013 | 3 | 8 |
| 2014 | 6 | 14 |
| 2015 | 7 | 12 |
| 2016 | 11 | 13 |
| 2017 | 6 | 13 |
| 2018 | 11 | 15 |
| 2019 | 9 | 11 |
| 2020 | 8 | 14 |
| 2021 | 11 | 13 |
| 2022 | 1 | 15 |
| 2023 | 6 | 4 |
| 2024 | 7 | 20 |
| 2025 | 7 | 44 |
| 2026 | 6 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modulating human Cas9-specific host immune response29 Sep 2026US 12,747,432 B2Arizona Board of Regents on behalf of Arizona State University
- Compositions and methods for CRISPR/Cas-based gene editing18 Aug 2026US 12,709,743 B2China Agricultural University
- Dnazymes for detecting Legionella pneumophila23 Jun 2026US 12,663,420 B2McMaster University
- Marker for acid sphingomyelinase disorders and uses thereof31 Mar 2026US 12,589,138 B2Genzyme Corporation
- Systems and methods for selective DNA multiple displacement amplification of a DNA mixture17 Mar 2026US 12,577,613 B2Genomic Labs Ltd
- Increasing the sensitivity of a crispr-cas nucleic acid detection system1 Oct 2026US 2026/0297656 A1Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek TNO
- Inhibitors of ets2-activating molecules for the treatment of inflammatory diseases17 Sep 2026US 2026/0273081 A1The Francis Crick Institute Limited
- A surface-based crispr nucleic acid detection10 Sep 2026US 2026/0265811 A1Siemens Healthineers Nederland B.V.
- Untargeted multiplexed in situ rna profiling and the uses and means therefor10 Sep 2026US 2026/0265819 A1Massachusetts Institute of Technology
- Mutated v-type crispr enzyme and use thereof27 Aug 2026US 2026/0250744 A1Beijing Synsorbio Technology Co., Ltd.
Most cited
By later US patents
- Method and agents for inhibiting protein aging104US 4,758,583 AThe Rockefeller University · 1988
- Methods for identifying a location of an RNA in a biological sample78US 11,761,038 B110x Genomics, Inc. · 2023
- Releasable nonvolatile mass label molecules69US 6,635,452 B1Sequenom, Inc. · 2003
- Mutant Cas9 proteins62US 9,074,199 B1President and Fellows of Harvard College · 2015
- Methods for identifying a location of an RNA in a biological sample53US 11,952,627 B210x Genomics, Inc. · 2024